KRYSTEXXA
Live / Registered — Registered and renewed (as of 22 Oct 2020)
What this means for you
Registered since 15 Feb 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Feb 2021).
Record
- Serial number
- 77552516
- Registration number
- 3920201
- Mark type
- Stylized text
- Filed
- 21 Aug 2008
- Published for opposition
- 13 Jan 2009
- Registered
- 15 Feb 2011
- Next maintenance due
- 15 Feb 2021
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of elevated levels of uric acid in the body and/or body fluids; biological and pharmaceutical preparations for the treatment of rheumatological conditions
Owner
- HORIZON THERAPEUTICS USA, INC., DEERFIELD, IL, US
- HORIZON PHARMA RHEUMATOLOGY LLC, LAKE FOREST, IL, US
- CREALTA PHARMACEUTICALS LLC, LAKE FOREST, IL, US
- Savient Pharmaceuticals, Inc., East Brunswick, NJ, US
- Savient Pharmaceuticals, Inc., East Brunswick, NJ, US
- Savient Pharmaceuticals, Inc., East Brunswick, NJ, US
Prosecution history
- 19 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Feb 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED